Novartis CEO lauds Trump administration plan to overhaul rebates
By John Miller ZURICH (Reuters) – Novartis AG Chief Executive Vas Narasimhan said his...
Read MoreFeb 7, 2019
By John Miller ZURICH (Reuters) – Novartis AG Chief Executive Vas Narasimhan said his...
Read MoreFeb 6, 2019
(Reuters) – An unidentified patient who was kept in isolation at a Philadelphia hospital while being tested for Ebola has been confirmed as not infected with the deadly virus, a hospital spokesman said on Wednesday....
Read MoreFeb 6, 2019
By Michael Erman NEW YORK (Reuters) – Drugmakers Pfizer Inc, Bristol-Myers Squibb Co and...
Read MoreFeb 6, 2019
By Lisa Rapaport (Reuters Health) – Older adults who get regular exercise are less likely to experience falls than their counterparts who are inactive, a research review suggests. Workouts that focus on balance and...
Read MoreFeb 6, 2019
By Lisa Rapaport (Reuters Health) – Almost two-thirds of patients in the U.S. who get medical marijuana are using it as a treatment for chronic pain, a new study suggests. That’s in line with the large number of...
Read MoreFeb 6, 2019
By Will Boggs MD (Reuters Health) – Higher education may build a stronger foundation for overall brain function, but starting from this higher level of function doesn’t influence how fast cognition declines in old...
Read MoreFeb 6, 2019
By Ceyda Caglayan and Ezgi Erkoyun ISTANBUL (Reuters) – The shelf of heart disease drugs in Hulya Akpinar’s Istanbul pharmacy is almost bare, and patients seeking medicine for blood pressure and diabetes leave...
Read MoreFeb 6, 2019
By Nate Raymond (Reuters) – The U.S. Justice Department on Wednesday said it had filed a...
Read MoreFeb 6, 2019
By Tamara Mathias (Reuters Health) – Certain tumors labeled as “cancer” aren’t life-threatening and should be called something else instead, some doctors believe. When patients receive a cancer diagnosis,...
Read MoreFeb 6, 2019
By Lawrence Hurley WASHINGTON (Reuters) – President Donald Trump urged lawmakers in his...
Read MoreFeb 6, 2019
By Lisa Rapaport (Reuters Health) – Many patient advocacy groups focused on skin conditions receive funding from companies that sell dermatology treatments, and a new study suggests these nonprofits don’t always...
Read MoreFeb 6, 2019
(Reuters) – The U.S. Food and Drug Administration (FDA) said on Wednesday it had approved Sanofi SA’s drug to treat a rare blood-clotting disorder in adults in combination with standard-of-care treatments. The...
Read MoreFeb 6, 2019
By Allison Martell and Anna Mehler Paperny TORONTO (Reuters) – Canadian pharmaceutical...
Read MoreFeb 6, 2019
By Tamara Mathias (Reuters) – Eli Lilly and Co on Wednesday embraced a U.S. government...
Read MoreFeb 6, 2019
By Catherine Lagrange LYON, France (Reuters) – A decade-old lawsuit in which a French farmer...
Read MoreFeb 6, 2019
TOKYO (Reuters) – Japan’s swine fever outbreak has spread to five prefectures...
Read MoreFeb 6, 2019
ZURICH (Reuters) – Switzerland’s Roche will donate its new hemophilia A drug Hemlibra...
Read MoreFeb 5, 2019
WASHINGTON (Reuters) – A bipartisan group of U.S. senators re-introduced a bill on Tuesday...
Read MoreFeb 5, 2019
By Lisa Rapaport (Reuters Health) – The idea that skipping breakfast contributes to weight gain doesn’t mean that eating breakfast can help with weight loss, a research review suggests. Researchers examined data from...
Read MoreFeb 5, 2019
By Linda Carroll (Reuters Health) – The e-prescription system bounced back quickly after two out of three major 2017 hurricanes, a new U.S. study finds. Recovery took much longer after the third, Hurricane Maria, most...
Read More